Picture of VentriPoint Diagnostics logo

VPT — VentriPoint Diagnostics Share Price

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m-5.26%
3m-37.58%
6m-2.92%
1yr+65%
Volume Change (%)
10d/3m-63.8%
Price vs... (%)
52w High-53.73%
50d MA-10.62%
200d MA-23.91%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-176.94%
Return on Equityn/a
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202131st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2021 / 2022

Blurred out image of VentriPoint Diagnostics EPS forecast chart

Profile Summary

Ventripoint Diagnostics Ltd. is a Canada-based medical device company that is primarily engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. The Company offers Ventripoint Medical System (VMS) equipment. The Company's VMS+ is a diagnostic aid, which is developed to provide a point-of care solution to communicate the heart's structure and function without the need for magnetic resonance imaging (MRI). Its VMS+ is designed to create a three-dimensional (3D) model of the heart from a two-dimensional (2D) echocardiogram and allows cardiac metrics on all four chambers of the heart within minutes. The Company enables VMS+ software to be installed on any personal workstation. The Company’s Knowledge Based Reconstruction (KBR) enables to construct a 3D model of the heart and calculates volumes and ejection fractions for all chambers. The Company has not generated any revenues.

Directors

Last Annual
December 31st, 2020
Last Interim
September 30th, 2021
Incorporated
September 18th, 2007
Public Since
November 9th, 2005
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
ca flag iconTSX Venture Exchange
Shares in Issue
153,643,905

VPT Share Price Performance

FAQ

Or unlock with your email

Or unlock with your email